Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander D Borgsteede

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 28, 2006
Good end-of-life care according to patients and their GPsSander D Borgsteede, Corrie Graafland-Riedstra, Luc Deliens, et al.
The Annals of Pharmacotherapy|April 15, 2010
What motivates patients to report an adverse drug reaction?Florence P A M van Hunsel, Elaine A A M ten Berge, Sander D Borgsteede, et al.
Frontiers in Pharmacology|May 28, 2020
Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross-Sectional Descriptive Study as Part of the PharmLines InitiativeMuh Akbar Bahar, Jens H J Bos, Sander D Borgsteede, et al.
Frontiers in Pharmacology|May 14, 2021
Medication-Related Problems in Liver Transplant Recipients in the Outpatient Setting: A Dutch Cohort StudyMidas B Mulder, Sander D Borgsteede, Sarwa Darwish Murad, et al.
Journal of Pain and Symptom Management|August 12, 2008
Trends in the use of opioids at the end of life and the expected effects on hastening deathMette L Rurup, Sander D Borgsteede, Agnes van der Heide, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2019
[Hypersensitivity reactions to excipients in patches]Marleen V Olthoff, A C M Kunkeler, Florence P A M van Hunsel, et al.
Frontiers in Pharmacology|October 15, 2019
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic ImpairmentRianne A Weersink, Lotte Timmermans, Margje H Monster-Simons, et al.
International Journal of Clinical Pharmacy|July 8, 2011
Factors related to high and low levels of drug adherence according to patients with type 2 diabetesSander D Borgsteede, Marjan J Westerman, Irene L Kok, et al.
Scandinavian Journal of Primary Health Care|November 29, 2007
Interdisciplinary cooperation of GPs in palliative care at home: a nationwide survey in The NetherlandsSander D Borgsteede, Luc Deliens, Gerrit van der Wal, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2019
[A body packer with cannabis]Sander D Borgsteede, Patricia E B Verwer, Gerrie Prins, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 28, 2006
Good end-of-life care according to patients and their GPsSander D Borgsteede, Corrie Graafland-Riedstra, Luc Deliens, et al.
The Annals of Pharmacotherapy|April 15, 2010
What motivates patients to report an adverse drug reaction?Florence P A M van Hunsel, Elaine A A M ten Berge, Sander D Borgsteede, et al.
Frontiers in Pharmacology|May 28, 2020
Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross-Sectional Descriptive Study as Part of the PharmLines InitiativeMuh Akbar Bahar, Jens H J Bos, Sander D Borgsteede, et al.
Frontiers in Pharmacology|May 14, 2021
Medication-Related Problems in Liver Transplant Recipients in the Outpatient Setting: A Dutch Cohort StudyMidas B Mulder, Sander D Borgsteede, Sarwa Darwish Murad, et al.
Journal of Pain and Symptom Management|August 12, 2008
Trends in the use of opioids at the end of life and the expected effects on hastening deathMette L Rurup, Sander D Borgsteede, Agnes van der Heide, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2019
[Hypersensitivity reactions to excipients in patches]Marleen V Olthoff, A C M Kunkeler, Florence P A M van Hunsel, et al.
Frontiers in Pharmacology|October 15, 2019
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic ImpairmentRianne A Weersink, Lotte Timmermans, Margje H Monster-Simons, et al.
International Journal of Clinical Pharmacy|July 8, 2011
Factors related to high and low levels of drug adherence according to patients with type 2 diabetesSander D Borgsteede, Marjan J Westerman, Irene L Kok, et al.
Scandinavian Journal of Primary Health Care|November 29, 2007
Interdisciplinary cooperation of GPs in palliative care at home: a nationwide survey in The NetherlandsSander D Borgsteede, Luc Deliens, Gerrit van der Wal, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2019
[A body packer with cannabis]Sander D Borgsteede, Patricia E B Verwer, Gerrie Prins, et al.
Pageof 6